Importing Canadian cannabis into Australia requires coordinating two regulatory frameworks at once: the Canadian export regime under the Cannabis Act and the Australian import regime administered by the Therapeutic Goods Administration (TGA) and the Office of Drug Control (ODC). Get both sides right and shipments move efficiently. Miss a step on either end and you're looking at customs holds, permit rejections, or product destruction.
This guide walks through the full import pathway for pharmaceutical-grade dried cannabis flower from a Canadian Licensed Producer to an Australian importer or distributor. It covers permit sequencing, product standards under TGO 93, labelling and documentation requirements, and the quality checks Australian importers typically apply before a shipment is accepted. Every step here reflects the real workflow as of 2026.
The Australian medical cannabis import framework
Australia operates a two-regulator system for medicinal cannabis imports. The TGA governs product quality and the therapeutic goods framework. The ODC governs the import permit itself, as cannabis remains a controlled substance under Australian law.
For a shipment to clear, three conditions must be true simultaneously: the Canadian LP holds a valid Health Canada export authorisation under the Cannabis Act, the Australian importer holds a current ODC import permit covering that specific batch and quantity, and the product meets TGO 93 standards as evidenced by a valid Certificate of Analysis (COA). See our guide to reading a cannabis COA for a detailed breakdown of what each section means for B2B buyers.
The most common breakdown point in Australia-bound shipments is permit sequencing. Both permits are batch-specific: they reference the product, quantity, and anticipated shipment window. A permit issued for 50 kg of one cultivar does not cover a substituted batch, even if potency is identical. Canadian exporters need to lock down batch selection and quantity before the Australian importer starts the ODC application.
Access pathways: SAS B vs Schedule 4
Most medicinal cannabis products from Canadian LPs enter Australia via one of two TGA pathways:
- Special Access Scheme Category B (SAS B): physician-initiated, product-specific access for individual patients. The majority of imported medicinal cannabis enters this way. Approval is granted per-patient, per-product.
- Schedule 4 Prescription Medicine: full TGA registration via the Australian Register of Therapeutic Goods (ARTG). Higher bar, longer process, but enables broad prescribing without per-patient approval. Very few imported cannabis products have cleared this pathway to date.
For Canadian LPs, the practical implication is that SAS B dominates near-term import volumes. Your Australian partner's prescriber network and SAS B approval rates are a meaningful indicator of how much product they can actually move.
TGO 93 product standards: what Canadian flower must meet
TGO 93 sets the minimum quality standards for medicinal cannabis in Australia. For dried flower, the key parameters are:
- Potency accuracy: Declared cannabinoid content (typically total THC and total CBD) must fall within the stated range. TGA tolerances are specific. A COA declaring 25% THC must be backed by reproducible batch testing from an ISO/IEC 17025 accredited laboratory.
- Microbial limits: TGO 93 specifies maximum counts for total aerobic bacteria, yeasts, moulds, and specified pathogens. Batch testing must confirm compliance before shipment.
- Pesticide residues: TGO 93 references the European Pharmacopoeia pesticide residue limits. Any pesticide detected above threshold is a rejection ground at the Australian border.
- Heavy metals: Lead, cadmium, arsenic, and mercury are each capped. Results must appear on the COA.
- Moisture content: Finished flower must fall within the acceptable moisture range to prevent microbial growth in transit and storage.
The practical implication for Canadian LPs: your COA needs to come from an ISO/IEC 17025 accredited laboratory and must explicitly address each TGO 93 parameter. A COA that omits the pesticide panel, or that reports individual cannabinoids without a total THC calculation, will not satisfy Australian importers or the TGA.
AlphaLeaf's COAs are issued by an accredited ISO/IEC 17025 laboratory and include full pesticide panels, heavy metals, microbiological screening, and moisture content alongside cannabinoid potency. Importers can request batch documentation as part of due diligence before signing a supply agreement.
The permit workflow: sequencing Canadian and Australian approvals
Getting the permit sequence right is where most first-time importers run into delays. Here is the order of operations that works in practice.
Step 1: Confirm batch and quantity
Before any permit application starts, the Canadian LP and the Australian importer must agree on the exact batch (lot number, cultivar, approximate quantity) being shipped. Both permits reference this information. Changes after permit issuance require amendments, which adds weeks to the timeline.
Step 2: Australian importer applies for ODC permit
The ODC import permit application requires: importer licence details, supplier details (the Canadian LP's Health Canada licence number and facility address), product description (cultivar, form, estimated THC and CBD), quantity in grams or kilograms, and the anticipated import window. ODC typically processes complete applications in 10 to 20 business days. Incomplete applications restart the clock.
Step 3: Canadian LP applies for Health Canada export permit
Under the Cannabis Act, a Canadian LP needs a valid export authorisation and, for each shipment, a permit referencing the importing country, importer, and product. Health Canada requires the Australian ODC import permit number as part of the export permit application. This is why the ODC permit comes first: you can't apply for the Canadian permit without it.
Step 4: Finalise documentation package
Before the shipment leaves Canada, the documentation package must include the Health Canada export permit, the ODC import permit copy, the batch COA, a commercial invoice with the appropriate narcotic HS code, a packing list, and any phytosanitary documentation required by the freight carrier or Australian customs. Your freight forwarder with narcotics experience will advise on route-specific requirements. AlphaLeaf's export team can share examples of documentation packages from past international shipments. Contact us via our international enquiry page.
What Australian importers look for in a Canadian LP
Australian importers and their procurement teams have reviewed a lot of Canadian LP applications since the market opened. The supply relationships that hold tend to share a few common qualities.
Consistent batch quality
Australian importers make SAS B applications on specific products with specific potency claims. A supply partner whose batch-to-batch cannabinoid variance is wide creates prescriber and patient risk. They'll ask for COAs from multiple batches before contracting, not just the most recent one. Full batch traceability from cultivation through to packaging is a procurement requirement for most Australian buyers, not an optional extra. Our overview of EU-GMP certification for Canadian LPs covers the quality documentation standards that international markets now expect as baseline.
Export track record and documentation readiness
A Canadian LP that has shipped to Germany or Israel has already worked through the permit workflow, COA requirements, and freight partner selection. That track record matters to Australian buyers. Be prepared to provide your Health Canada licence documentation, export authorisation confirmation, and examples of past shipment documentation packages on request.
Supply reliability and minimum order clarity
Australian importers plan SAS B approvals and prescriber supply around specific product SKUs. If production runs are inconsistent or minimum order quantities are unclear, that creates supply chain risk for their physician network. Be explicit about your production cycle, minimum order quantities, and lead time from order confirmation to shipment readiness.
AlphaLeaf supplies hand-trimmed, large-bud dried flower with full batch traceability from our Montreal indoor facility. Our Ice Cream Cake cultivar (30.3% THC, Wedding Cake x Gelato cross, large-bud format above 5cm) is produced at consistent potency across batches. We hold export authorisation under the Cannabis Act and our COA documentation is issued by an ISO/IEC 17025 accredited laboratory. Contact our team via the international enquiry form to discuss Australian supply terms.
Frequently Asked Questions
Does Canada allow cannabis exports to Australia?
Yes. Canadian Licensed Producers with an export authorisation under the Cannabis Act can export dried cannabis flower to Australia. The shipment must also satisfy Australian import requirements, including an ODC import permit and TGO 93 product standards.
What is TGO 93 and why does it matter for Canadian exporters?
TGO 93 is Australia's Therapeutic Goods Order No. 93, which sets mandatory quality and safety standards for medicinal cannabis products. Canadian cannabis intended for the Australian market must meet TGO 93 specifications for potency, microbial limits, pesticide residues, heavy metals, and packaging before the TGA will allow it into the therapeutic goods system.
Who applies for the Australian import permit, the Canadian exporter or the Australian importer?
The Australian importer holds the ODC import permit. The Canadian Licensed Producer handles the Health Canada export permit on its end. Both permits must be in place before a shipment can legally move, and their batch and quantity references must match.
How long does an ODC import permit take to obtain?
ODC import permit processing typically takes 10 to 20 business days from a complete application. Applications submitted with incomplete batch data, mismatched quantity references, or missing supplier documentation take longer. Planning permit applications at least six weeks before a target ship date is standard practice.
Does a Canadian GMP certificate satisfy Australian import requirements?
Health Canada GMP certification is recognised by the TGA under bilateral arrangements, and many Australian importers accept it alongside a COA from an ISO/IEC 17025 accredited laboratory. Some importers also request EU-GMP certification or a TGA GMP clearance, particularly for products entering the Schedule 4 pathway. Confirm the specific GMP expectation with your Australian importer before contracting.
